Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model

  • Authors:
    • Juan Ye
    • Xueting Cai
    • Dawei Wang
    • Furong Zhang
    • Zhigang Wang
    • Meng Cao
    • Zhonghua Pang
    • Jie Yang
    • Huaijiang Yan
    • Jing Li
    • Peng Cao
    • Chunping Hu
  • View Affiliations

  • Published online on: July 13, 2020     https://doi.org/10.3892/etm.2020.8994
  • Pages: 2845-2855
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The use of Shi Xiao San (SXS), composed of Pollen Typhae Angustifoliae and Faeces Trogopterori, can be traced back to the Song dynasty. Traditionally, SXS has been used to treat irregular menstruation, pelvic pain, progressive dysmenorrhea, and postpartum lochiorrhea. The management of adenomyosis (AM) is challenging and to the best of our knowledge there are currently no effective therapeutic strategies. Therefore, the aim of the present study was to investigate the effect of SXS on the development of adenomyosis in a mouse model. AM was induced in 60 neonatal female ICR mice by administering tamoxifen; 10 randomly selected mice were used for model identification via histopathological examination and 10 mice treated with the solvent alone were used as the normal controls. A total of sixty days after birth, the mice treated with AM were randomly divided into four groups and administered one of the following treatments: Low‑dose SXS (55 mg/kg); high‑dose SXS (110 mg/kg); danazol (1 mg/20 g body weight); or no treatment (model group); at the same time, the normal control group received no treatment. After 2 months of treatment, hotplate and tail‑flick tests were used to assess the response to noxious thermal stimuli in the mice, and plasma samples were collected to measure corticosterone levels. Hematoxylin and eosin staining scores of myometrial infiltration and the number of AM nodules were evaluated. Furthermore, the expression of genes associated with AM‑related pain was also analyzed. The results from the present study indicated that treatment with SXS decreased myometrial infiltration, alleviated generalized hyperalgesia, and lowered plasma corticosterone levels in mice with induced AM. These findings suggest that SXS effectively attenuated the development of AM, and may serve as a promising treatment approach for AM treatment.

Related Articles

Journal Cover

September-2020
Volume 20 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Ye J, Cai X, Wang D, Zhang F, Wang Z, Cao M, Pang Z, Yang J, Yan H, Li J, Li J, et al: Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model. Exp Ther Med 20: 2845-2855, 2020
APA
Ye, J., Cai, X., Wang, D., Zhang, F., Wang, Z., Cao, M. ... Hu, C. (2020). Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model. Experimental and Therapeutic Medicine, 20, 2845-2855. https://doi.org/10.3892/etm.2020.8994
MLA
Ye, J., Cai, X., Wang, D., Zhang, F., Wang, Z., Cao, M., Pang, Z., Yang, J., Yan, H., Li, J., Cao, P., Hu, C."Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model". Experimental and Therapeutic Medicine 20.3 (2020): 2845-2855.
Chicago
Ye, J., Cai, X., Wang, D., Zhang, F., Wang, Z., Cao, M., Pang, Z., Yang, J., Yan, H., Li, J., Cao, P., Hu, C."Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model". Experimental and Therapeutic Medicine 20, no. 3 (2020): 2845-2855. https://doi.org/10.3892/etm.2020.8994